Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIAID

PRODUCTION OF ATTENUATED PARAINFLUENZA VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES

  • Read more about PRODUCTION OF ATTENUATED PARAINFLUENZA VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES
Japan
2008-107219
Filed on 2008-04-19

Molecular Scaffolds For HIV-1 Epitopes

  • Read more about Molecular Scaffolds For HIV-1 Epitopes
US Patent 8,637,234
Filed on 2007-10-19

MOLECULAR SCAFFOLDS FOR HIV-1 EPITOPES

  • Read more about MOLECULAR SCAFFOLDS FOR HIV-1 EPITOPES
Patent Cooperation Treaty
PCT/US2005/011928
Filed on 2005-04-08

NON-VIRAL GENE DELIVERY COMPLEX

  • Read more about NON-VIRAL GENE DELIVERY COMPLEX
US Application 12/092,811
Filed on 2008-05-06

Ribosomal Protein S3: A Functional Component Of NF-KappaB p65 Binding Complexes

  • Read more about Ribosomal Protein S3: A Functional Component Of NF-KappaB p65 Binding Complexes
Patent Cooperation Treaty
PCT/US2008/061306
Filed on 2008-04-23

PSM PEPTIDES AS VACCINE TARGETS AGAINST COMMUNITY-ACQUIRED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS

  • Read more about PSM PEPTIDES AS VACCINE TARGETS AGAINST COMMUNITY-ACQUIRED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS
Patent Cooperation Treaty
PCT/US2008/063119
Filed on 2008-05-08

The Overlapping Reading Frames Of The P/C Gene Of HPIV1 Have Been Separated To Generate A Recombinant HPIV1 (rHPIV1) Expressing The P And C Proteins From Separate Genes.

  • Read more about The Overlapping Reading Frames Of The P/C Gene Of HPIV1 Have Been Separated To Generate A Recombinant HPIV1 (rHPIV1) Expressing The P And C Proteins From Separate Genes.
Patent Cooperation Treaty
PCT/US2008/063033
Filed on 2008-05-08

Monoclonal Antibodies Against Dengue And Other Viruses With Deletion Of Fc Region

  • Read more about Monoclonal Antibodies Against Dengue And Other Viruses With Deletion Of Fc Region
Patent Cooperation Treaty
PCT/US2008/059313
Filed on 2008-04-03

IL-21 Receptor Deficiency Reduces Type-2 Immunity, Inflammmation And Tissue Fibrosis

  • Read more about IL-21 Receptor Deficiency Reduces Type-2 Immunity, Inflammmation And Tissue Fibrosis
China
200680021090.6
Filed on 2006-04-13

RECOMBINANT PROTEINS OF A PAKISTANI STRAIN OF HEPATITIS E AND THEIR USE IN DIAGNOSTIC METHODS AND VACCINES

  • Read more about RECOMBINANT PROTEINS OF A PAKISTANI STRAIN OF HEPATITIS E AND THEIR USE IN DIAGNOSTIC METHODS AND VACCINES
European Patent
08004467.0
Filed on 1998-04-09

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 397
  • Page 398
  • Page 399
  • Page 400
  • Page 401
  • Page 402
  • Page 403
  • Page 404
  • Page 405
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIAID
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health